Resource Center: Drug seeking

Article describing eight different ways to identify and help drug-seeking patients in your practice.

This 2008 Physician Clinical Support System (PCSS) document written by Dr. Judith Martin discusses types of aberrant behavior associated with buprenorphine and steps that can be taken to reduce the risk of abuse and diversion.

Situations in which legitimate narcotic users can be misidentified as drug misusers.

This 2006 document explains the Drug Enforcement Agency's (DEA) role in regulation of controlled substances and the physician's legal responsibility to prescribe controlled substances for legitimate medical purposes.

This is the full text of Title 21, Chapter 13 of the US Code, which deals with drug abuse prevention and control.

These FAQs address common questions regarding prescription drug monitoring programs.

This presentation examines issues that have arisen in buprenorphine treatment to date and suggests measures that can be taken to address these issues going forward.

Manual written by the DEA to assist physicians in understanding and complying with the Federal Controlled Substances Act. Topics covered include recordkeeping requirements, rules regarding prescription, and security requirements.

This is the NASPER website which includes various information on the $60 million dollar 2005 grant to help states start or improve state-run prescription monitoring programs (PMPs).

RADARS®, the Researched Abuse, Diversion, and Addiction-Related Surveillance System, tracks prescription drug abuse, misuse and diversion throughout the United States. It is a nonprofit operation of the Rocky Mountain Poison and Drug Center, a division of Denver Health.